Nov 092017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NJ – Immunomedics, Inc., (NASDAQ:IMMU) today announced that its Board of Directors has appointed Michael Pehl as President and Chief Executive Officer, effective December 7, 2017.… => Read more

Immunomedics announces Michael Pehl to its Board of Directors as upcoming CEO

From:: Immunomedics announces Michael Pehl to its Board of Directors as upcoming CEO

Sorry, the comment form is closed at this time.

%d bloggers like this: